Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Labopharm's once-daily tramadol rolled out across Europe

Jan. 12, 2007

PRO-513 gives relief from pain, nausea, photophobia and phonophobia in migraine

Jan. 11, 2007

Low LDL-C linked to high incidence of Parkinson's disease: statins may lower risk for the disease

Jan. 11, 2007

Fentora studies show onset of pain relief within 10 minutes

Jan. 11, 2007

BF-2649 increases wakefulness and cognition in preclinical studies

Jan. 11, 2007

Patents disclose therapeutic agents for schizophrenia, depression and other psychological disorders

Jan. 10, 2007

Boehringer Ingelheim and Ablynx to develop Nanobodies for Alzheimer's

Jan. 10, 2007

Phase II/III pain program outlined for Anesiva's 4975

Jan. 10, 2007

Depression and anxiety compound TC-2216 begins phase I trial

Jan. 10, 2007

Novartis reports positive preclinical results of novel Nurr1 activator

Jan. 10, 2007

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...